Results 231 to 240 of about 3,517,895 (261)

Underestimation of Subserosal Invasion in Early Gastric Cancer‐Like Advanced Gastric Carcinoma With Focal Enteroblastic Differentiation: A Case Report

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Early gastric cancer (EGC)‐like advanced gastric cancer (AGC) is a rare entity that mimics superficial disease despite deep invasion. We report a case of EGC‐like AGC with focal enteroblastic differentiation in which subserosal invasion was underestimated because of its superficially appearing endoscopic features.
Akira Tomioka   +8 more
wiley   +1 more source

Transpapillary/Transfistular Drainage for Two Refractory Postoperative Right‐Lobe Bilomas: A Case Report

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT We report a case of two refractory postoperative right‐lobe bilomas that were successfully treated with transpapillary/transfistular (TP/TF) drainage. A 57‐year‐old man developed two bilomas (segments 6 and 7) after repeated hepatectomy for colorectal liver metastases.
Fumitaka Niiya   +5 more
wiley   +1 more source

Combining fruquintinib with TAS-102 as a promising strategy: antitumor activity in preclinical colorectal and gastric cancer xenograft models. [PDF]

open access: yesBMC Cancer
Hara T   +9 more
europepmc   +1 more source

Feasibility and Safety Profile of Non‐anesthesiologist‐administered Propofol During Colorectal Endoscopic Submucosal Dissection: A Single‐center Study of 454 Procedures

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Studies of non‐anesthesiologist‐administered propofol (NAAP) during colorectal endoscopic submucosal dissection (ESD) are scarce, particularly in the elderly. We evaluated its feasibility across a broad age range and identified factors associated with sedation‐related adverse events.
Yumi Kishi   +16 more
wiley   +1 more source

Evaluation of Mutation Risk Using Patient‐Derived Organoids in Patients With Lynch Syndrome

open access: yesInternational Journal of Cancer, Volume 159, Issue 10, Page 2585-2594, 15 November 2026.
ABSTRACT Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes, most notably associated with colorectal cancer. Although LS patients face high risk of CRC, risk can vary even among those with the same pathogenic MMR germline mutations. We suggest a functional assay platform for
Youmi Shin   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy